XML 22 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Cash receipts from customers $ 186,500 $ 173,728
Cash paid for inventory, prescriptions dispensed and health services rendered (101,198) (90,845)
Insurance benefits paid (58,844) (52,485)
Cash paid to other suppliers and employees (18,630) (21,124)
Interest and investment income received 972 839
Interest paid (1,484) (1,392)
Income taxes paid (863) (729)
Net cash provided by operating activities 6,453 7,992
Cash flows from investing activities:    
Proceeds from sales and maturities of investments 6,866 4,418
Purchases of investments (7,186) (6,781)
Purchases of property and equipment (1,350) (1,343)
Acquisitions (net of cash and restricted cash acquired) (139) (73)
Other 23 60
Net cash used in investing activities (1,786) (3,719)
Cash flows from financing activities:    
Commercial paper borrowings (repayments), net 921 (200)
Proceeds from issuance of long-term debt 0 4,959
Repayments of long-term debt (762) (37)
Repurchase of common stock 0 (3,024)
Dividends paid (1,706) (1,698)
Proceeds from exercise of stock options 191 228
Payments for taxes related to net share settlement of equity awards (125) (176)
Other (45) (30)
Net cash provided by (used in) financing activities (1,526) 22
Net increase in cash, cash equivalents and restricted cash 3,141 4,295
Cash, cash equivalents and restricted cash at the beginning of the period 8,884 8,525
Cash, cash equivalents and restricted cash at the end of the period 12,025 12,820
Reconciliation of net income to net cash provided by operating activities:    
Net income 2,795 2,892
Adjustments required to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 2,325 2,289
Stock-based compensation 262 270
Loss on sale of subsidiary 236 0
Deferred income taxes and other items (283) (341)
Change in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable, net (4,139) 2,798
Inventories 671 1,937
Other assets (969) (2,241)
Accounts payable and pharmacy claims and discounts payable 3,831 1,191
Health care costs payable and other insurance liabilities (34) 1,581
Other liabilities 1,758 (2,384)
Net cash provided by operating activities $ 6,453 $ 7,992